Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

24 April 2025

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

72423 result(s) found, displaying 7551 to 7575

RISPERIDONE-AS risperidone 3mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
RISPERIDONE-AS risperidone 3mg film-coated tablet bottle Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
RISPERIDONE-AS risperidone 4mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
RISPERIDONE-AS risperidone 4mg film-coated tablet bottle Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
RISPERIDONE-AS risperidone 6mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
RISPERIDONE-AS risperidone 6mg film-coated tablet bottle Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
RISPERIDONE-GA risperidone 2mg tablets bottle Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
RISPERIDONE-GA risperidone 3mg tablets bottle Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
RISPERIDONE-GA risperidone 4mg tablets bottle Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
RISPERIDONE-GA risperidone 6mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
RISPERIDONE-GA risperidone 6mg tablets bottle Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
RIZATRIPTAN ACTAVIS rizatriptan (as benzoate) 10 mg orodispersible tablet blister pack Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
RIZATRIPTAN ACTAVIS rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ROCAN 0.2% (w/v) ropivacaine hydrochloride (as monohydrate) 20 mg/10 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ROCAN 0.2% (w/v) ropivacaine hydrochloride (as monohydrate) 200 mg/100 mL solution for injection bag Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ROCAN 0.2% (w/v) ropivacaine hydrochloride (as monohydrate) 40 mg/20 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ROCAN 0.2% (w/v) ropivacaine hydrochloride (as monohydrate) 400 mg/200 mL solution for injection bag Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ROCAN 0.5% (w/v) ropivacaine hydrochloride (as monohydrate) 100 mg/20 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ROCAN 0.5% (w/v) ropivacaine hydrochloride (as monohydrate) 50mg/10mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ROCAN 0.75% (w/v) ropivacaine hydrochloride (as monohydrate) 150 mg/20 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ROCAN 0.75% (w/v) ropivacaine hydrochloride (as monohydrate) 75 mg/10 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ROCAN 1% (w/v) ropivacaine hydrochloride (as monohydrate) 100 mg/10 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ROCAN 1% (w/v) ropivacaine hydrochloride (as monohydrate) 200 mg/20 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
SALBUTAMOL-PS salbutamol (as sulfate) 2.5mg/2.5mL inhalation solution ampoule Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
SALBUTAMOL-PS salbutamol (as sulfate) 5mg/2.5mL inhalation solution ampoule Cancelled under Section 30(1)(c) of the Act

17 September 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd

Last updated

24 April 2025

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Cancellations by sponsors

Filter results

Decision type

Date of effect

RISPERIDONE-AS risperidone 3mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

RISPERIDONE-AS risperidone 3mg film-coated tablet bottle Cancelled under Section 30(1)(c) of the Act

RISPERIDONE-AS risperidone 4mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

RISPERIDONE-AS risperidone 4mg film-coated tablet bottle Cancelled under Section 30(1)(c) of the Act

RISPERIDONE-AS risperidone 6mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

RISPERIDONE-AS risperidone 6mg film-coated tablet bottle Cancelled under Section 30(1)(c) of the Act

RISPERIDONE-GA risperidone 2mg tablets bottle Cancelled under Section 30(1)(c) of the Act

RISPERIDONE-GA risperidone 3mg tablets bottle Cancelled under Section 30(1)(c) of the Act

RISPERIDONE-GA risperidone 4mg tablets bottle Cancelled under Section 30(1)(c) of the Act

RISPERIDONE-GA risperidone 6mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

RISPERIDONE-GA risperidone 6mg tablets bottle Cancelled under Section 30(1)(c) of the Act

RIZATRIPTAN ACTAVIS rizatriptan (as benzoate) 10 mg orodispersible tablet blister pack Cancelled under Section 30(1)(c) of the Act

RIZATRIPTAN ACTAVIS rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack Cancelled under Section 30(1)(c) of the Act

ROCAN 0.2% (w/v) ropivacaine hydrochloride (as monohydrate) 20 mg/10 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

ROCAN 0.2% (w/v) ropivacaine hydrochloride (as monohydrate) 200 mg/100 mL solution for injection bag Cancelled under Section 30(1)(c) of the Act

ROCAN 0.2% (w/v) ropivacaine hydrochloride (as monohydrate) 40 mg/20 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

ROCAN 0.2% (w/v) ropivacaine hydrochloride (as monohydrate) 400 mg/200 mL solution for injection bag Cancelled under Section 30(1)(c) of the Act

ROCAN 0.5% (w/v) ropivacaine hydrochloride (as monohydrate) 100 mg/20 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

ROCAN 0.5% (w/v) ropivacaine hydrochloride (as monohydrate) 50mg/10mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

ROCAN 0.75% (w/v) ropivacaine hydrochloride (as monohydrate) 150 mg/20 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

ROCAN 0.75% (w/v) ropivacaine hydrochloride (as monohydrate) 75 mg/10 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

ROCAN 1% (w/v) ropivacaine hydrochloride (as monohydrate) 100 mg/10 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

ROCAN 1% (w/v) ropivacaine hydrochloride (as monohydrate) 200 mg/20 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

SALBUTAMOL-PS salbutamol (as sulfate) 2.5mg/2.5mL inhalation solution ampoule Cancelled under Section 30(1)(c) of the Act

SALBUTAMOL-PS salbutamol (as sulfate) 5mg/2.5mL inhalation solution ampoule Cancelled under Section 30(1)(c) of the Act

Is there anything wrong with this page?

Site notifications

Cancellations by sponsors

Filter results

Decision type

Date of effect

Is there anything wrong with this page?